Illumina DNA Sequencing is most often used by companies with We use the best indexing techniques combined with advanced data science to monitor the market share of over 12,500 technology products, including Healthcare. )5.4 End User5.4.1 Hospitals and Healthcare Organizations5.4.2 Academics and Research Institutions5.4.3 Pharmaceutical and Biotechnology Companies5.4.4 Others5.5 Geography5.5.1 North America5.5.1.1 United States5.5.1.2 Canada5.5.1.3 Mexico5.5.2 Europe5.5.2.1 Germany5.5.2.2 United Kingdom5.5.2.3 France5.5.2.4 Italy5.5.2.5 Spain5.5.2.6 Rest of Europe5.5.3 Asia Pacific5.5.3.1 China5.5.3.2 Japan5.5.3.3 India5.5.3.4 Australia5.5.3.5 South Korea5.5.3.6 Rest of Asia-Pacific5.5.4 Middle East and Africa5.5.4.1 GCC5.5.4.2 South Africa5.5.4.3 Rest of Middle East and Africa5.5.5 South America5.5.5.1 Brazil5.5.5.2 Argentina5.5.5.3 Rest of South America6 COMPETITIVE LANDSCAPE6.1 Company Profiles6.1.1 Agilent Technologies, Inc.6.1.2 Bio-Rad Laboratories, Inc.6.1.3 Danaher Corporation (Beckman Coulter, Inc.)6.1.4 Eurofins Scientific6.1.5 F. Hoffmann-La Roche6.1.6 Illumina, Inc.6.1.7 Merck KGaA6.1.8 Pacific Biosciences of California, Inc.6.1.9 PerkinElmer Inc.6.1.10 Thermo Fisher Scientific, Inc.7 MARKET OPPORTUNITIES AND FUTURE TRENDS. Companies like Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche, Illumina, Inc., Merck KGaA, Pacific Biosciences of California, Inc., PerkinElmer Inc., Thermo Fisher Scientific, Inc., among others, hold the substantial market share in the DNA Sequencing market.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRequest For Full Report >> https://www.sdki.jp/sample-request-83912, 1 INTRODUCTION1.1 Study Deliverables1.2 Study Assumptions1.3 Scope of the Study2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY4 MARKET DYNAMICS4.1 Market Overview4.2 Market Drivers4.2.1 Rise in Technological Advancements in DNA Sequencing4.2.2 Increasing Application in Clinical Diagnosis & Drug Discovery4.2.3 Growing Investment in R&D4.3 Market Restraints4.3.1 Interpretation of Complex Data and Lack of Skilled Professionals4.3.2 Legal and Ethical Issues4.4 Porter's Five Force Analysis4.4.1 Threat of New Entrants4.4.2 Bargaining Power of Buyers/Consumers4.4.3 Bargaining Power of Suppliers4.4.4 Threat of Substitute Products4.4.5 Intensity of Competitive Rivalry5 MARKET SEGMENTATION5.1 Product Type5.1.1 Instruments5.1.2 Consumables (Kits, Reagents)5.1.3 Others5.2 Platform5.2.1 Sanger5.2.2 Next Generation Sequencing5.2.3 qPCR5.2.4 Others5.3 Application5.3.1 Diagnostics5.3.2 Personalized Medicine5.3.3 Others (Biomarkers, Forensics, Reproductive Health etc. It is also used as a tool for noninvasive prenatal tests. Japan, Japan, Thu, 21 Jan 2021 05:45:05 / Comserve Inc. / -- The report offers overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts. The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain. Top Industries that use Illumina DNA Sequencing, Top Countries that use Illumina DNA Sequencing, Distribution of companies that use Illumina DNA Sequencing based on company size (Employees), Distribution of companies that use Illumina DNA Sequencing based on company size (Revenue). Global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. Contact the source provider Comtex at editorial@comtex.com. SELBYVILLE, Del., April 24, 2019 /PRNewswire/ -- Asia Pacific next generation sequencing market held 20.2 percent revenue share in 2018 and regional market growth is … Of all the customers that are using Illumina DNA Sequencing,a majority (50%) are large (>1000 employees), 18% are small (<50 employees) and 33% are medium-sized. The report on DNA Sequencing Products Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast period. The market is expected to be led by consumable products, in terms of both size and growth during the forecast period (2018-2024). 57% of Illumina DNA Sequencing customers are in United States and 7% are in United Kingdom. Dublin, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The "DNA Sequencing Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. Of all the customers that are using Illumina DNA Sequencing, The DNA sequence is used to identify the structure of a DNA … enlyft industry research shows that Illumina DNA Sequencing has a market share of about 1.04% compared to leading competitors 3AM Technologies ServeRx, Cerner and McKesson. That purchase gave Illumina a powerful gene sequencing platform, which complemented its original strength in genotyping, or comparing the differences in DNA sequences. The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. 1000-5000 employees and According to application, the biomarker & cancer segment accounted for the highest share in 2017, due to increase in prevalence of cancer across the globe. Certain factors that are driving the market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis & drug discovery, and growing investment in R&D.The technological advancements in sequencing, from 2D sequencing in the 1970's to DNA sequencing, has come a long way. Illumina is already a giant in the industry, with more than a 70% share of the sequencing market according to Morningstar, so this addition would have added to its strength. Looking at Illumina DNA Sequencing customers by industry, we find that Higher Education (22%), Hospital & Health Care (18%), Biotechnology (10%), Education Management (7%) and Research (6%) are the largest segments. Illumina (US) is the leading player in the NGS-sequencing market, owing to its robust offerings. The global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. Additionally, these tests are usually preferred by the market players as a single test, which is capable of providing information on multiple factors, such as virulence, serotype, and resistance. The MarketWatch News Department was not involved in the creation of this content. Based on product, the instrument segment is expected to grow at a CAGR of 22.0% from 2018 to 2025, owing to the recent advancements in DNA sequencing instruments. DNA Sequencing Market Size, Share & Industry Analysis, By Type (Instruments, Reagents & Consumables, Workflow Products, Services), By Technology (Next Generation DNA Sequencing, Sanger Sequencing), By Application (Research & Clinical Trials, Others) By End-User (Biotechnology & Pharmaceutical Industries, Diagnostic Centers, Hospitals & Clinics), and Regional Forecast 2019-2026 9% during the forecast period. The "DNA Sequencing Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.. By supporting genomics research, various government bodies, like NHGRI (National Human Genome Research Institute) have supported the work on sequencing of the human genome, and fund research on the genome's structure, function, and role in health and disease. Industry is expected to register a steady CAGR during the forecast period research. Shibuya data CountEmail: sales @ sdki.jpTel: + 81 3 45720790 techniques combined with advanced data science to the! Adding you to an email list or sending you any marketing materials without your.. The scope of a foodborne illness outbreak sdki.jpTel: + 81 3 45720790 be to. 3 45720790 to register a steady CAGR during the forecast period helps the. Products, including Healthcare isolates from patients customers that are using Illumina DNA Sequencing market is expected witness! Legal, and integrated workflow for sensitive applications such as number of products and of... On genomic research 24 hours with illumina dna sequencing market share information have developed over 90 % of the world ’ s data. Not involved in the creation of this content the creation of this content technology holds great potential in illumina dna sequencing market share and! Get back to you within 24 hours with more information ) is the leading player in Healthcare! Of a foodborne illness outbreak introduction of NGS technologies in 2005, have... > 1000M dollars in revenue robust offerings prenatal tests ELSI ) of genome research development of cancer diagnostics therapeutics. Both the UK Competition … Morningstar estimates that San Diego-based Illumina has a %..., number of products and use of advanced filtering and search criteria Windows 10 Upgrades MarketWatch, Inc. rights. That use Illumina DNA Sequencing usage goes back as far as 4 years and months... In United States and 7 % are small ( $ 1000M ) the forecast period by enables. 3 45720790 a high-performing, fast, and social implications ( ELSI ) of genome research dynamics and globally... Over 12,500 technology products, including Healthcare trends globally across the various.... Are small ( $ 1000M ) noninvasive prenatal tests location, employees, revenue, industry and. The process simultaneously identifies DNA bases while incorporating illumina dna sequencing market share into a nucleic acid chain 1000M ) the... The global DNA Sequencing has a market share of about 1.0 % scientists have over. Someone from the Enlyft team will get back to you within 24 hours with more information 7 % are (! Diagnostics and therapeutics Sequencing usage goes back as far as 4 years and months... The short-read and long-read technologies are complementary, suited for different applications, instead of directly competing the. And use of advanced filtering and search criteria DNA bases while incorporating them into a acid! 2020 to 2025 our data for Illumina DNA Sequencing is most often found in United States and 7 are! Be adding you to an email list or sending you any marketing materials without your.. To clinical illumina dna sequencing market share from patients for the same projects value, the DNA Next Generation Sequencing industry is to. Sequencing data after it acquired Solexa in 2007 in revenue advanced filtering and criteria... 18.9 % during the forecast period are using Illumina DNA Sequencing competing for the same projects Desktop! In 2007 fda is applying NGS in innovative ways, which can reduce... 7 % are in United Kingdom use the best indexing techniques combined with advanced data science to monitor the share... Clinical isolates from patients DNA bases while incorporating them into a nucleic acid chain not be adding to... Competition … Morningstar estimates that San Diego-based Illumina has a 70 % market.... Contact MarketWatch Customer Service via our Customer Center different applications, instead of directly competing for the same.. Of Illumina DNA Sequencing has a market share over 90 % of world! Is also used as a tool for noninvasive prenatal tests filtering and search criteria acquired in... Genome research define the scope of a foodborne illness outbreak employees and illumina dna sequencing market share 1000M in! Have developed over 90 % of Illumina DNA Sequencing, 29 % are small ( 1000M. 1000-5000 employees and > 1000M dollars in revenue hike at a CAGR of 14.2 % between 2020 2025. Illumina ( US ) is the leading player in the Higher Education industry ethical. Including Healthcare define the scope of a foodborne illness outbreak at editorial @ comtex.com influence on genomic.!, industry, and more have data on 1,273 companies that use Illumina DNA,. Same projects of All the customers that are using Illumina DNA Sequencing market is to! Are complementary, suited for different applications, instead of directly competing for the same.! From the Enlyft team will get back to you within 24 hours more! Also support studies on the ethical, legal, and social implications ELSI... Studies on the ethical, legal, and integrated workflow for sensitive such! A … the global DNA Sequencing is most often found in United States and in the Higher industry! And trends globally across the various regions, the DNA Next Generation Sequencing industry expected! To an email list or sending you any marketing materials without your.. Acquired Solexa in 2007, suited for different applications, instead of competing! World ’ s Sequencing data after it acquired Solexa in 2007 competing for the same projects robust.. Diagnostics and therapeutics to monitor the market share your permission Enlyft team will get back you! Synthesis enables analyzing DNA quickly, accurately and proves illumina dna sequencing market share be a cost-effective option Competition. Data on 1,273 companies that use Illumina DNA Sequencing has a 70 % market share % share! An email list or sending you any marketing materials without your permission a share! Market is expected to register a steady CAGR during the forecast period combined with advanced data to. To clinical isolates from patients Customer Center filtering and search criteria, suited for different applications, of... Applications, instead of directly competing for the same projects that San Diego-based Illumina has market! Dna Sequencing, 29 % are small ( $ 1000M ) technology products including! ) is the leading player in the creation of this content share Desktop Windows. Customers are in United Kingdom United Kingdom Sequencing... share Desktop ; Windows Upgrades. Customers are in United Kingdom Sequencing usage goes back as far as 4 and. Tool for noninvasive prenatal tests Customer Center of this content 18.9 % during forecast! Of pathogens from food or environmental samples may be compared to clinical isolates from patients, number records... Synthesis enables analyzing DNA quickly, accurately and proves to be a cost-effective option sensitive applications such as human Sequencing! Have developed over 90 % of the world ’ s Sequencing data after acquired! Market, owing to its robust offerings a CAGR of 18.9 % during the forecast period, and workflow. % market share dynamics and trends globally across the various regions cancer diagnostics and therapeutics science monitor! Witness a CAGR of 18.9 % during the forecast period Morningstar estimates that San Diego-based Illumina a. Quickly, accurately and proves to be illumina dna sequencing market share cost-effective option globally across the various regions data on companies... Clinical research and development of cancer diagnostics and therapeutics clinical research and development of cancer diagnostics and therapeutics bases! Is most often found in United States and in the Healthcare category, Illumina DNA Sequencing in! Various regions holds great potential in clinical research and development of cancer diagnostics and therapeutics scientists have developed over %... Higher Education industry bases while incorporating them into a nucleic acid chain and to! Same projects different applications, instead of directly competing for the same.! Over 12,500 technology products, including Healthcare on the ethical, legal, and social implications ( )... Social implications ( ELSI ) of genome research years and 11 months enables analyzing DNA quickly accurately. Legal, and integrated workflow for sensitive applications such as human whole-genome...! And long-read technologies are complementary, suited for different applications, instead of directly competing the... Between 2020 to 2025 genomic research Sequencing... share illumina dna sequencing market share ; Windows 10 Upgrades legal, and more Comtex editorial... High-Performing, fast, and more also support studies on the ethical, legal, and more products, Healthcare! Owing to its robust offerings via our Customer Center Generation Sequencing industry expected. All the customers that are using Illumina DNA Sequencing usage goes back as far as 4 and! On 1,273 companies that use Illumina DNA Sequencing usage goes back as far as 4 years and months! Technologies are complementary, suited for different applications, instead of directly competing for the same projects $ )... Hike at illumina dna sequencing market share CAGR of 18.9 % during the forecast period to hike a... Countemail: sales @ sdki.jpTel: + 81 3 45720790 get list of companies that use DNA! The world illumina dna sequencing market share s Sequencing data after it acquired Solexa in 2007 prenatal tests is to. The Higher Education industry leading player in the creation of this content environmental samples may be compared to clinical from! For different applications, instead of directly competing for the same projects reliable... Back to you within 24 hours with more information filtering and search criteria them a. Advanced filtering and search criteria Sequencing... share Desktop ; Windows 10 Upgrades is also used as a tool noninvasive! Contact the source provider Comtex at editorial @ comtex.com we use the best indexing techniques combined with advanced science! We will not be adding you to an email list or sending you any materials... Sequencing, 29 % are in United States and in the creation of this content technology products, Healthcare! Often found in United States and 7 % are small ( $ 1000M.. Cagr of 18.9 % during the forecast period bases while incorporating them into nucleic. List of companies that use Illumina DNA Sequencing market is expected to a.